NexgenRx Inc. (NEGXF) Stock
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About NexgenRx Inc.
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada. Beyond core claims handling, NexgenRx offers Health Care Spending Accounts (HCSAs), providing individuals with dedicated funds for their health or dental expenses. Its service portfolio also encompasses individual and aggregate stop-loss insurance products, emergency medical and travel assistance insurance, and a suite of administrative support functions. These administrative services include the collection and disbursement of premiums for life and long-term disability (LTD) coverage, complemented by advanced reporting tools. To enhance convenience, the company facilitates online claims submission and direct deposit services, along with other specialized ancillary services.
NexgenRx Inc. is headquartered in CA.
NexgenRx Inc. (NEGXF) stock trades at $0.33 with a market capitalization of $23.11M. The stock is valued at a price-to-earnings (P/E) ratio of 18.07, price-to-book of 3.68, price-to-sales of 1.77. Over the past 52 weeks the stock has ranged between $0.20 and $0.33, and currently trades at its 52-week high. It pays a dividend yielding 3.03%.
On profitability, NexgenRx Inc. generates a return on equity (ROE) of 24.30% — well above the market average, a sign of a high-quality business, return on capital employed of 31.54%, an operating margin of 15.70%, a net profit margin of 10.88%.
Official website: www.nexgenrx.com